VisionWave CEO resigns, interim CEO appointed; $398K loan and LOI with CM

VisionWave Holdings, Inc.

Noam Kenig resigned as CEO and director effective Dec 29, 2025, for personal reasons; no disagreement with company.
Executive Chairman Douglas Davis appointed as Interim CEO; Eric Shuss named Independent Lead Director.
Company advanced $398,345 to C.M. Composite Materials via promissory note due Dec 31, 2027, with 5% interest on default.
Company entered into amended LOI for potential strategic transaction with CM; no assurance of consummation.

item 1.01 item 5.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001731122-25-001741
form_type: 8-K
ticker: VWAV
cik: 0002038439
company_name: VisionWave Holdings, Inc.
filed_at: 2025-12-30T23:59:59+00:00
discovered_at: 2026-05-14T18:02:41.433467+00:00
generated_at: 2026-05-16T12:02:46.341391+00:00
sec_items: ["1.01", "5.02", "8.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001731122-25-001741
json_url: https://secwatch.observer/filing/0001731122-25-001741.json
markdown_url: https://secwatch.observer/filing/0001731122-25-001741.md
text_url: https://secwatch.observer/filing/0001731122-25-001741.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2038439/000173112225001741/0001731122-25-001741-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2038439/000173112225001741/e7167_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001731122-25-001741

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.